Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Cuttner

Showing results (21-30 of 89) with videos related to

Pageof 9
Sort By:
Seminars in Oncology|September 1, 1984
Mitoxantrone as a single agent and in combination chemotherapy in patients with refractory acute leukemiaP A Paciucci, J Cuttner, J F Holland
American Journal of Hematology|September 1, 1990
Sequential intermediate-dose cytosine arabinoside and mitoxantrone for patients with relapsed and refractory acute myelocytic leukemiaP A Paciucci, J Cuttner, J F Holland
Cancer|October 1, 1978
Phase I study with neocarzinostatin: tolerance to two hour infusion and continuous infusionT Ohnuma, C Nogeire, J Cuttner, et al.
Cancer Treatment Reports|September 1, 1985
Therapy for chronic myelogenous leukemia in blast crisis with etoposide and 5-azacitidine administered by continuous infusion: a Cancer and Leukemia group B StudyC A Schiffer, K Anderson, M Coleman, et al.
American Journal of Hematology|July 1, 1985
Tartrate-resistant acid phosphatase staining of monocytes in Gaucher diseaseK Troy, J Cuttner, M Reilly, et al.
Israel Journal of Medical Sciences|July 1, 1977
Chemoimmunotherapy in acute myelocytic leukemiaJ F Holland, J G Bekesi, J Cuttner, et al.
Cancer Research|October 1, 1987
Mitoxantrone, vincristine, and prednisone in adults with relapsed or primarily refractory acute lymphocytic leukemia and terminal deoxynucleotidyl transferase positive blastic phase chronic myelocytic leukemiaP A Paciucci, C Keaveney, J Cuttner, et al.
American Journal of Hematology|July 1, 1991
Protein C and S levels in acute leukemiaK Troy, D Essex, J Rand, et al.
American Journal of Hematology|July 1, 1984
Confirming evidence for the clonal development and stem cell origin of Philadelphia chromosome-negative chronic myelogenous leukemiaF J Kaye, V Najfeld, J Singer, et al.
The Journal of Experimental Medicine|December 1, 1982
Association of certain Ia allotypes with the occurrence of chronic lymphocytic leukemia. Recognition by a monoclonal anti-Ia reagent of a susceptibility determinant not in the DR seriesA Nunez-Roldan, I Szer, T Toguchi, et al.
Pageof 9

Showing results (21-30 of 89) with videos related to

Sort By:
Pageof 9
Seminars in Oncology|September 1, 1984
Mitoxantrone as a single agent and in combination chemotherapy in patients with refractory acute leukemiaP A Paciucci, J Cuttner, J F Holland
American Journal of Hematology|September 1, 1990
Sequential intermediate-dose cytosine arabinoside and mitoxantrone for patients with relapsed and refractory acute myelocytic leukemiaP A Paciucci, J Cuttner, J F Holland
Cancer|October 1, 1978
Phase I study with neocarzinostatin: tolerance to two hour infusion and continuous infusionT Ohnuma, C Nogeire, J Cuttner, et al.
Cancer Treatment Reports|September 1, 1985
Therapy for chronic myelogenous leukemia in blast crisis with etoposide and 5-azacitidine administered by continuous infusion: a Cancer and Leukemia group B StudyC A Schiffer, K Anderson, M Coleman, et al.
American Journal of Hematology|July 1, 1985
Tartrate-resistant acid phosphatase staining of monocytes in Gaucher diseaseK Troy, J Cuttner, M Reilly, et al.
Israel Journal of Medical Sciences|July 1, 1977
Chemoimmunotherapy in acute myelocytic leukemiaJ F Holland, J G Bekesi, J Cuttner, et al.
Cancer Research|October 1, 1987
Mitoxantrone, vincristine, and prednisone in adults with relapsed or primarily refractory acute lymphocytic leukemia and terminal deoxynucleotidyl transferase positive blastic phase chronic myelocytic leukemiaP A Paciucci, C Keaveney, J Cuttner, et al.
American Journal of Hematology|July 1, 1991
Protein C and S levels in acute leukemiaK Troy, D Essex, J Rand, et al.
American Journal of Hematology|July 1, 1984
Confirming evidence for the clonal development and stem cell origin of Philadelphia chromosome-negative chronic myelogenous leukemiaF J Kaye, V Najfeld, J Singer, et al.
The Journal of Experimental Medicine|December 1, 1982
Association of certain Ia allotypes with the occurrence of chronic lymphocytic leukemia. Recognition by a monoclonal anti-Ia reagent of a susceptibility determinant not in the DR seriesA Nunez-Roldan, I Szer, T Toguchi, et al.
Pageof 9